Treatment Effect and Safety of Nanoliposomal Irinotecan with Fluorouracil and Folinic Acid after Gemcitabine-Based Therapy in Patients with Advanced Pancreatic Cancer: A Multicenter, Prospective Observational Study

Although the combination of nanoliposomal irinotecan plus fluorouracil/folinic acid (nal-IRI/FF) exhibited survival benefits in gemcitabine-refractory patients with advanced pancreatic cancer (APC) in the phase III NAPOLI-1 trial, there is limited data on the efficacy and safety of this regimen in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Miki, Masami, Fujimori, Nao, Ueda, Keijiro, Lee, Lingaku, Murakami, Masatoshi, Takamatsu, Yu, Shimokawa, Yuzo, Niina, Yusuke, Oono, Takamasa, Hisano, Terumasa, Furukawa, Masayuki, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457338/
https://www.ncbi.nlm.nih.gov/pubmed/36079012
http://dx.doi.org/10.3390/jcm11175084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457338/
https://www.ncbi.nlm.nih.gov/pubmed/36079012
http://dx.doi.org/10.3390/jcm11175084

Ejemplares similares